Identifying high-risk components in online adaptive RT through a multi-centre FMEA to inform clinical trial QA needs.

Saved in:
Bibliographic Details
Title: Identifying high-risk components in online adaptive RT through a multi-centre FMEA to inform clinical trial QA needs.
Authors: Osman SO; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Northwood, London, UK; Department of Radiotherapy Physics, University College London Hospital, London, UK. Electronic address: sarah.osman8@nhs.net., Dunlop A; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, UK., Alexander S; The Royal Marsden NHS Foundation Trust, London, UK., Berresford J; The Christie NHS Foundation Trust, Manchester, UK., Bidmead M; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, UK., Bolt M; Royal Surrey Hospital NHS Foundation Trust, Guildford, Surrey, UK., Brewster F; The Christie NHS Foundation Trust, Manchester, UK., Chauhan J; GenesisCare, UK., Díez P; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Northwood, London, UK; Mount Vernon Cancer Centre, Northwood, London, UK., Eccles CL; The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK., George B; GenesisCare, UK., Graham S; Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Herbert T; The Royal Marsden NHS Foundation Trust, London, UK., Hollingdale R; Royal Surrey Hospital NHS Foundation Trust, Guildford, Surrey, UK., Kidane G; Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., McQuaid D; Royal Surrey Hospital NHS Foundation Trust, Guildford, Surrey, UK., Miles E; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Northwood, London, UK; Mount Vernon Cancer Centre, Northwood, London, UK., Mitchell A; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, UK., Rashid M; Royal Surrey Hospital NHS Foundation Trust, Guildford, Surrey, UK., Thomas M; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, UK., Wai P; GenesisCare, UK., Withers D; Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Clark CH; National Radiotherapy Trials Quality Assurance (RTTQA) Group, Northwood, London, UK; Department of Radiotherapy Physics, University College London Hospital, London, UK; National Physical Laboratory, Teddington, London, UK.
Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2026 Jun; Vol. 219, pp. 111526. Date of Electronic Publication: 2026 Apr 09.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0887
DOI:10.1016/j.radonc.2026.111526